Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression

Cervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimoto, Taishi, Takasawa, Akira, Takasawa, Kumi, Aoyama, Tomoyuki, Murata, Masaki, Osanai, Makoto, Saito, Tsuyoshi, Sawada, Norimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141703/
https://www.ncbi.nlm.nih.gov/pubmed/30227306
http://dx.doi.org/10.1016/j.neo.2018.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141703/
https://www.ncbi.nlm.nih.gov/pubmed/30227306
http://dx.doi.org/10.1016/j.neo.2018.08.010

Ejemplares similares